{"slideshow_credits": null, "snippet": "The company said that the Food and Drug Administration rejected its application saying too much information was missing from studies to accurately gauge the drug\u2019s benefit.", "abstract": null, "section_name": "Business Day", "print_page": "", "document_type": "article", "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "web_url": "http://www.nytimes.com/2014/02/15/business/still-no-expansion-for-johnson-johnson-blood-thinner.html", "lead_paragraph": "The company said that the Food and Drug Administration rejected its application saying too much information was missing from studies to accurately gauge the drug\u2019s benefit.", "headline": {"main": "Still No Expansion for Johnson & Johnson Blood Thinner", "print_headline": "Still No Expansion For J.&amp;J. Blood Thinner ", "content_kicker": "Business Briefing"}, "_id": "52feb98a38f0d826f8460e1f", "word_count": "83", "multimedia": [], "pub_date": "2014-02-15T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Johnson & Johnson", "name": "organizations", "is_major": "N", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}